Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
The American Journal of Pathology|August 9, 2011
Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma modelAlexander R Abbas, Janet K Jackman, Sherron L Bullens, et al.American Journal of Respiratory and Critical Care Medicine|October 25, 2017
IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in AsthmaNirav R Bhakta, Stephanie A Christenson, Srilaxmi Nerella, et al.Pulmonary Pharmacology & Therapeutics|June 1, 2022
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationHubert Chen, Rebecca Kunder, Yixuan Zou, et al.Allergy|May 17, 2022
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthmaLatifa Khalfaoui, Fiona A Symon, Simon Couillard, et al.Arthritis Research & Therapy|August 29, 2014
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeuticsGlynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, et al.Allergy|September 9, 2024
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthmaHorace Rhee, Lindsay M Henderson, Rebecca N Bauer, et al.JCI Insight|October 5, 2016
Depletion of major pathogenic cells in asthma by targeting CRTh2Tao Huang, Meredith Hazen, Yonglei Shang, et al.Critical Care (London, England)|June 13, 2023
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsisCarrie M Rosenberger, Katherine D Wick, Hanjing Zhuo, et al.Science Translational Medicine|April 20, 2022
Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthmaRiccardo Guidi, Daqi Xu, David F Choy, et al.The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.Pageof 7